AstraZeneca Says Its CCP Virus Vaccine Triggers Encouraging Immune Response

AstraZeneca Says Its CCP Virus Vaccine Triggers Encouraging Immune Response
Prime Minister Scott Morrison takes a tour at the AstraZeneca laboratories in Macquarie Park, in Sydney, Australia, on Aug. 19, 2020. Nick Moir/Pool/Getty Images
Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:
AstraZeneca’s CCP virus vaccine is producing an encouraging immune response among both older and younger adults, the drugmaker said on Oct. 26.

AstraZeneca, which is developing the possible vaccine along with the University of Oxford, said adverse responses to the vaccine among the elderly were found to be lower.

Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics